Introduction {#s1}
============

The morphological diversity of body wall muscles is necessary for precision, strength and coordination of body movements specific to each animal species. The development of the complex architecture of the body wall musculature of the *Drosophila* larva -- 30 different muscles in each hemi-segment ([@bib3]) -- is a classical model to decrypt transcription regulatory networks controlling muscle morphological diversity. Each muscle is a single multinucleated fiber built by fusion of a Founder Cell (FC) with fusion competent myoblasts (FCMs). Muscle identity - orientation, shape, size, attachment sites - reflects the expression by each FC of a specific combination of identity Transcription Factors (iTFs). Establishment of the FC iTF code starts with activation of specific muscle iTFs, in response to positional information from the ectoderm which defines equivalence groups of myoblasts within each segment, called promuscular clusters (PMCs) ([@bib11]; [@bib4]). The second step is the selection of progenitor cells (PCs) from each PMC, via interplay between Ras signaling and Notch (N)/Delta-mediated lateral inhibition, the unselected myoblasts becoming FCMs ([@bib12]). The third step is the asymmetric division of each PC into two FCs or, in some cases, one FC and one adult muscle precursor cell (AMP) or pericardial cell. Asymmetric division leads to maintaining expression of some iTFs in one FC and their repression by N signaling in the sibling cell, thereby contributing to muscle lineage diversity ([@bib60]; [@bib13]). This henceforth classical, three-step model of muscle identity specification relies heavily on positional information conferring each muscle its identity ([@bib68]). Interestingly, pioneering studies showed that specification of two nearby Even-skipped (Eve) expressing PCs was sequential ([@bib10]; [@bib38]), but the link between PC birth time and muscle identity remained to be explored.

We have previously shown that four PCs, at the origin of one dorsal muscle (DA2) and one AMP, and the 6 dorso-lateral (DL) muscles, DA3, DO3, DO4, DO5, DT1, and LL1, are serially selected from a PMC expressing Collier (Col/Kn, Early B-Cell Factor (EBF) in vertebrates ([@bib22]). More precisely, the DA2/AMP, DA3/DO5 and LL1/DO4 PCs are sequentially selected at roughly identical positions in thoracic and abdominal segments, while the DO3/DT1 PC is selected at a slightly posterior position and only in abdominal segments ([@bib7]; [@bib34]; [Figure 1A](#fig1){ref-type="fig"}). Beyond the PC step, *col* transcription is only maintained in the DA3 muscle ([@bib20]), while other iTFs, the C2H2 zinc finger protein Krüppel (Kr), the homeodomain protein S59 (vertebrate NKx1.1) and the Lim-homeodomain protein Tailup (Tup/Islet1) are expressed in the LL1, DT1 and DA2 lineages, respectively ([@bib28]; [@bib60]; [@bib7]). Serial emergence of DL PCs, followed by lineage-specific expression of different iTFs, raised the question of how PC selection timing and muscle identity were linked. The discovery that Tup expression led to *col* repression in the DA2/AMP PC, thereby distinguishing between DA2 and DA3 identities, provided a first insight into this question. We indeed found that the time lag between DA2/AMP and DA3/DO5 PC selection coincides with the period of dorsal regression of Tinman (Tin; vertebrate Nkx2.5) expression ([@bib43]), such that only the first-born DA2 PC inherits Tin levels above the threshold required for activation of *tup* and imposing a DA2 fate. Yet, our understanding of how conjunction of developmental time and position translates into muscle-specific iTF codes, remained fragmentary.10.7554/eLife.14979.003Figure 1.Genetic identification of muscle identity genes.(**A**) Diagrammatic representation of the sequential emergence of four PCs (large cells) from the Col expressing PMC, followed by PC into FC divisions (embryonic stages (st) 10--12.5) and the corresponding muscle pattern at stage 15. The name of each PC, FC and muscle is indicated. Col expression is in red, color intensity indicating expression level. (**B**) Gene density along chromosome 2L and 2R, schematized by black bars. Position and size of each of 36 regions identified in our screen are indicated by red or blue bars. (**C**) Pie chart showing repartition of the DA3 phenotypes into two classes of generic (blue), and identity (red) defects. (**D**--**I**) Col immunostaining of late stage 15 embryos; (**D**) wt and (**E**--**I**), representative examples (deficiency name indicated) of each phenotypic class. The asterisk in (**D**,**E**,**H**) labels a dorsal class IV md neuron expressing Col. In this, and following figures, lateral views of embryos are shown, anterior to the left. (**J**,**K**) Pie charts associating individual genes with generic myogenic (**K**) or identity (**L**) mutant phenotypes. See also [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"} for phenotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.003](10.7554/eLife.14979.003)10.7554/eLife.14979.004Figure 1---source data 1.36 chromosomal deficiencies showing DA3 muscle phenotypes.Numbering indicates the position of the deleted region along the chromosome, schematized in [Figure 1B](#fig1){ref-type="fig"}. The phenotypes observed at embryonic stage 16 were classified as either identity or generic muscle defects, and ranked in different types ([Figure 1C](#fig1){ref-type="fig"}). Identified genes responsible for the deficiency phenotype are indicated together with their known or predicted biochemical function.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.004](10.7554/eLife.14979.004)10.7554/eLife.14979.005Figure 1---figure supplement 1.EGF-R signaling is required for a normal pattern of DL muscles.(**A**,**B**) wt DA3 Col expression at stage 16 (**A**), is lost in *star (S^IIN^*) mutant embryos (**B**). Insets show Col expression in the DA3/DO5 (white arrowhead) and DT1/DO3 (black arrowhead) PCs (stage 11). Col expression is only detected in the posterior-most DT1/DO3 PC in *S^IIN^* mutants (**B**). (**C**--**D**) MHC staining of wt (**C**) and *S^IIN^* (**D**) embryos; the DA2 is present (arrowhead in **D** compare to **C**) in *S^IIN^* embryos, while the only DL muscle forming in absence of EGF-R signaling is DT1 (arrow in **D**, compare to **C**). Of note, muscles issued from dorsal PCs, including the alary muscles, form.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.005](10.7554/eLife.14979.005)

Here, we identified several new muscle TFs, starting from a systematic deficiency screen of the second chromosome, i.e., roughly 40% of the *Drosophila* genome. We describe the roles of No Ocelli (Noc), a NET family zinc finger protein ([@bib16]), Sine oculis (So), a member of the Six family of homeodomain proteins ([@bib17]; [@bib65]; [@bib44]), and the co-factor ETS domain lacking Edl ([@bib1]; [@bib73]; [@bib56]) in DL muscle development, and in more detail, roles of Eyes-absent (Eya), a partner of Six proteins ([@bib55]), and Anterior open (Aop), an Ets-domain transcription repressor ([@bib58]; [@bib72]). Analysis of the *aop, edl, eya, noc* and *so* muscle mutant phenotypes and time windows of transcription, combined with *col* transcription in the different mutant contexts, revealed a cascade of regulations including coherent and incoherent feed-forward loops, which link PC selection time to muscle identity. *aop* and *edl* control the temporal sequence of DL PC selections, *eya* is required in PCs for maintaining iTF transcription, while *so* and one *eya*-specific isoform are deployed at the FC step. Finally, *noc* regulates expression of other iTFs, at the PC or FC step, depending upon the muscle lineage. Integration of these new data with pre-existing knowledge provides a comprehensive, dynamic view of the transcriptional control of muscle identity in *Drosophila*, and an extended framework for studies of interactions between general myogenic factors such as Nautilus (Nau)/MyoD and Eya, and iTFs in the diversification of muscle lineages during animal evolution.

Results {#s2}
=======

A genetic screen for muscle defects {#s2-1}
-----------------------------------

In order to identify new muscle identity genes, we screened a collection of 389 overlapping deficiencies, each deleting between 10 and 15 genes, and together covering about 80% of the *Drosophila* second chromosome ([@bib15]). Homozygous deficiency embryos were first examined for DA3 Col expression at the end of the fusion phase, embryonic stage 15. Nuclear Col localization allowed appraisal both of DA3 formation and shape, the number and spatial distribution of DA3 nuclei, and the presence of ectopic Col-expressing muscles. General embryonic defects could be identified by the loss, or gross disturbance of Col expression elsewhere, in the central and peripheral nervous systems, and/or lymph gland ([@bib31]), and the corresponding chromosomal deficiencies were not considered here. 36 were retained ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). The observed DA3 phenotypes were divided into two broad classes ([Figure 1C](#fig1){ref-type="fig"}): Class 1: Decreased number or abnormal repartition of nuclei ([Figure 1E--F](#fig1){ref-type="fig"} compare to [Figure 1D](#fig1){ref-type="fig"}); Class 2: Abnormal DA3 orientation and/or either loss of Col expression or ectopic Col expression in additional muscles ([Figure 1G--I](#fig1){ref-type="fig"} compare to [Figure 1D](#fig1){ref-type="fig"}). Three deletions showing both DA3 abnormal orientation and low nuclei number were considered as class 2 (regions 3, 4 and 30, [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Class 1 phenotypes have previously been observed in myoblast fusion or nuclei migration mutants which affect roughly equally all muscles ([@bib35]; [@bib62]) and were considered here as \'generic myogenesis\' defects ([Figure 1C](#fig1){ref-type="fig"} and [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). Class 2 phenotypes were reminiscent of either iTF or *Notch (N*) mutants ([@bib60]; [@bib20]; [@bib68]) and considered as \'muscle identity\' defects ([Figure 1C](#fig1){ref-type="fig"} and [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}).

To identify the gene(s) whose loss caused a DA3 phenotype in mapped deletions, we tested the most promising candidates for which loss of function mutants were available. Genes for which mutants over the deficiency reproduced the deficiency phenotype were selected for further analysis. From a total of 36 different chromosomal regions, we identified 9 genes out of 10 regions linked to generic defects and 15 genes in 14 regions linked to identity defects ([Figure 1J,K](#fig1){ref-type="fig"} and [Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}). The relevant gene(s) in 12 other regions remain to be identified. Seven of the nine genes in the generic class encode cytoskeletal or membrane-associated proteins with an already well-known role in either myoblast fusion or nuclei repartition in muscle syncitia, validating our screen ([Figure 1J](#fig1){ref-type="fig"}; [@bib45]). The eigth gene is *sin3A*, a chromatin binding protein present in transcription repressor complexes, also required for a normal pattern of myoblast fusions ([@bib26]). The 9^th^ gene is *basigin* (*bsg*), a predicted igG family plasma membrane protein, interacting with integrin ([@bib21]), whose role in muscle development has not been assessed.

Among the 15 genes associated with identity phenotypes ([Figure 1K](#fig1){ref-type="fig"}), six encoded components of either the N or Robo/Slit signaling pathways, two pathways previously implicated at different steps of DA3 muscle formation ([@bib20]; [@bib53]) and were therefore not further studied. Four other encoded components of the EGF-R signaling pathway: *spitz (spi), Star (S), aop (*also called *yan;* Flybase FBgn 000097), and *edl* (also called *mae*; Flybase FBgn0023214), while a deficiency (Df(2R)BSC259) removing both mesodermal FGFs, *Thisbe* and *Pyramus*, ([@bib66]) did not show a DA3 phenotype. A complete lack of DA3, DO5, DO4 and LL1 muscles in mutants for either *spi (spi^IIA^*), the EGF-R signal, or *Star (S^IIN^*), a chaperone protein required for Spi processing ([@bib40]), confirmed the central role of Epidermal Growth Factor-Receptor (EGF-R) signaling in specification of these DL muscles ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

New transcriptional regulators involved in muscle identity {#s2-2}
----------------------------------------------------------

Seven identity genes encoded transcriptional regulators, and potentially, new muscle iTFs: *aop, edl, eya, noc, so, spalt major (salm*) and *tup* ([Figures 1K](#fig1){ref-type="fig"} and [2A--F](#fig2){ref-type="fig"}). Previous studies showed that the Ets-domain transcription activator Pointed (Pnt), and transcription repressor Aop/Yan ([@bib72]; [@bib58]), promoted and inhibited the formation of Eve-expressing dorsal PCs, respectively, downstream of EGF-R signaling ([@bib38]; [@bib12]). The mesodermal function of *edl* remained, however, unknown. Comparing the *aop* and *edl* phenotypes thus provided an opportunity to further characterize outputs of EGF-R signaling in muscle identity specification. Whereas we previously reported *tup* function in dorsal muscle identity, neither function of *noc, salm* nor *so* in muscle development was previously characterized. *Drosophila* Six4 and So are orthologous to Six proteins which interact with Eya in mouse myogenic progenitors ([@bib39]; [@bib59]). *eya* was proposed to interact with *Six4* in *Drosophila* somatic muscle development, both genes showing similar expression patterns ([@bib19]; [@bib48]). Our identification of *so* mutants in our screen and the difference between the *eya* and *so* phenotypes ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}) called for a detailed comparison of *eya* and *so* expression and function in muscle PCs.10.7554/eLife.14979.006Figure 2.Specific muscle patterning defects in *aop, edl, eya, noc* and *so* mutant embryos.(**A**--**F**) Late stage 15 embryos stained for Col, to visualize the DA3 muscle. (**A**) wt, (**B**--**F**) embryos homozygous mutant for *aop, edl, eya, noc* and *so* null alleles with their names indicated. Inserts in (**A**,**B**,**D**,**E**) show Col expression in PCs, stage 11. (**G**--**L**) stage 16 embryos stained for Col (red) and β3-tubulin (green) to visualize all body wall muscles; arrowheads point to LT1 and LT2, asterisks indicate DT1; DA2 is surrounded by a line in G,I, and LL1 by a dotted line in **G**. (**G**) wt embryo. (**H**) *aop^1^* (**I**) *edl^l19^*; Col is expressed in DA2 and DA3. (**J**) *eya^CII^/Df(2L)^BSC354^*; DA3 Col expression is lost; inset, LL1\>DA3 transformation. (**K**) *noc^35ba2^*: Col expression is lost. (**L**) *so^3^*; Col expression in DO5 (arrow). (**M**--**R**) Stage 16 embryos stained for β3-tubulin (blue), βPS integrin (green), to visualize tendon cell-muscle connections and moeGFP (red) expressed under control of a DA3-specific *col* CRM (*col^LCRM^*), abbreviated *col-gfp*. Only βPS integrin and moeGFP are shown, except insets. (**M**) wt; DA3 ventral and dorsal attachment along the anterior and posterior segmental borders, respectively, are indicated by asterisks; inset, DT1 (arrowhead). (**N**) *aop*; DA3 with both DA3 and DA2-like (arrowhead) anterior attachments; DA3\>DA2 transformation, inset. (**O**) *edl*: moeGFP expression in DA2 and DA3 (arrow and inset). The arrow indicates partial DA2\>DA3 transformation; inset, bifid anterior DA3 attachment. (**P**) *eya*: moeGFP is lost in most segments or indicates partial or complete (inset) DA3\>DA2 transformation. (**Q**) *noc*: DA3\>DT1 transformation, resulting in DT1 (arrowhead in inset) duplication. (**R**) *so*: moeGFP expression in DO5; DO5\>DA3 transformation (arrowhead) in some segments. (**S**--**X**) Schematic diagram of the most frequent DA2 and DL muscle phenotypes in *aop, edl, eya, noc* and *so* mutants; Col expression is in red; see [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"} for statistics. Bars: 30 μm**DOI:** [http://dx.doi.org/10.7554/eLife.14979.006](10.7554/eLife.14979.006)10.7554/eLife.14979.007Figure 2---source data 1.Quantification of muscle phenotypes observed in *aop, edl, eya, noc* and *so* mutant stage 15 embryos.DA3\>DA2: complete or partial DA3 into DA2 muscle orientation; DA2\>DA3: complete or partial DA2 into DA3 muscle orientation; Col^exp^DO5: DO5 muscle expressing Col. Loss of Col: loss of DA3 muscle Col expression. DA3\>DT1 transformations have been quantified in *col^LCRM^-moeGFP* embryos.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.007](10.7554/eLife.14979.007)10.7554/eLife.14979.008Figure 2---figure supplement 1.*salm^1^* is required for proper skeletal attachment and morphology of the DA3 muscle.(**A**,**C**,**C'**) wt, and (**B**,**D**,**D'**) *salm^1^*mutant stage 16 embryos. (**A**,**B**) Staining for Col (red) and β3-tubulin (green). (B) the white arrow and arrowhead point to a loose DA3 anterior attachment and a vertical DA3 fiber with no posterior attachment, respectively; the inset shows dorsal muscles without defined posterior attachment sites. (**C**,**D**) Staining for MoeGFP expressed under control of a DA3-specific CRM (*^colL^*CRM) (green) and βPS integrin (red). No βPS integrin accumulation is detected at the position of DL muscle attachment sites (white asterisks) in *salm^1^* mutant embryos (**C'**,**D'**).**DOI:** [http://dx.doi.org/10.7554/eLife.14979.008](10.7554/eLife.14979.008)10.7554/eLife.14979.009Figure 2---figure supplement 2.Snapshots for [Videos 1](#media1){ref-type="other"}--[6](#media6){ref-type="other"}.Snapshots of [Videos 1](#media1){ref-type="other"}--[6](#media6){ref-type="other"} , showing β3-tubulin staining of muscles (green) and Col expression (red) in stage 16 embryos. Five segments are shown in (**A**--**D**), two in (**E**--**G**). (**A**,**E**--**E"**) wt embryos, [Video 1.](#media1){ref-type="other"} (**B**) *aop^1^* mutant, [Video 2](#media2){ref-type="other"}. (**C**) *edl^l19^*, [Video 3](#media3){ref-type="other"}. (**D**) *noc^35ba2^*, [Video 5](#media5){ref-type="other"}. (**F**) *eya^CII^/Df(2L)^BSC354^*, [Video 4](#media4){ref-type="other"}. (**G**) *so^3^*, [Video 6](#media6){ref-type="other"}. The positions of DA3, and DA2 and DA3 muscles are indicated in **A**,**F**,**G**, and **C**, respectively. DA2 is circles in **A** and LL1 in **E**,**F**. **E**,**E"**, **F**,**F"**, and **G**,**G"** are single channel in black and white, **E'F'**,**G'** green chanel, **E"**,**F"**,**G"** red channel. DO5\>DA3 and LL1\>DA3 transformations are indicated in **F**,**F"** and **G**,**G",** and **F**, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.009](10.7554/eLife.14979.009)

*aop, edl, eya, noc* and *so* muscle phenotypes {#s2-3}
-----------------------------------------------

To better assess the muscle phenotypes associated with each mutant, we examined the pattern of DL muscles in late stage 15 embryos immunostained for β3Tubulin, using Col staining to visualize DA3 ([Figure 2G--L](#fig2){ref-type="fig"}, [Video 1](#media1){ref-type="other"}). In addition, we introduced the DA3-specific *col^LCRM^-moeGFP* reporter gene ([@bib34]), to precisely visualize the DA3 contours in these mutant backgrounds. Stability of the MoeGFP fusion protein also allowed following \'DA3\' muscles in *noc* and *eya* mutants which lack Col expression ([Figure 2M--R](#fig2){ref-type="fig"}). In order to verify that muscle phenotypes were not associated with defective tendon cell differentiation, we stained mutant embryos for βPS integrin which accumulates at muscle-tendon junctions ([@bib47]). Based on this analysis, we eliminated *salm (salm^1^*) mutants which exhibited a phenotype reminiscent of defective tendon cells ([@bib64]; [@bib67]; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Unlike *salm*, no βPS integrin accumulation defects were detected in null mutants for *aop (aop^1^), edl (edl^L19^), noc (noc^35ba2^), eya (eya^CII-IID^),* and *so (so^3^*) mutants ([Figure 2M--R](#fig2){ref-type="fig"}), confirming muscle identity defects.Video 1.3-D view of the muscle pattern in stage 16 wt embryos, [Figure 2G](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.010](10.7554/eLife.14979.010)10.7554/eLife.14979.010

In *aop* mutants, the DA3 muscle(s) was misshapen in 2/3 of segments (n = 123), with cases of DA3 to DA2 transformation (DA3\>DA2; [Figure 2B](#fig2){ref-type="fig"}, [Figure 2--- figure supplement 2](#fig2s2){ref-type="fig"}, [Video 2](#media2){ref-type="other"} and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). The DT1 and LL1 muscles were also malformed in 40% segments (in 48/123 and 47/123 segments, respectively) and lateral and ventral muscles were severely disorganized. The DA2 muscle was unaffected ([Figure 2H](#fig2){ref-type="fig"}---and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). *col^LCRM^-moeGFP* expression confirmed an abnormal shape of the DA3 muscle suggestive of partial DA3\>DA2 transformation ([Figure 2N,T](#fig2){ref-type="fig"}). In *edl* mutants, a second Col-expressing muscle was observed in some segments, sometimes associated with morphological change suggestive of DA2\>DA3 transformation ([Figure 2C,I](#fig2){ref-type="fig"}, [Figure 2--- figure supplement 2](#fig2s2){ref-type="fig"}, [Video 3](#media3){ref-type="other"} and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). The DT1 muscle was either absent or too de-structured to be assigned specific identities (in 61/124 segments; [Figure 2I](#fig2){ref-type="fig"}). *col^LCRM^-moeGFP* expression confirmed a DA2\>DA3 transformation in 47% of segments ([Figure 2O](#fig2){ref-type="fig"}), but also revealed a number of reciprocal at least partial DA3\>DA2 transformations (16/124 segments) ([Figure 2O](#fig2){ref-type="fig"} inset---and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). In *eya* mutants, DA3 Col expression was lost, a loss already observed at the PC stage ([Figure 2D,J](#fig2){ref-type="fig"}). Consistent with loss of Col expression early during muscle specification, the DL muscle pattern was severely disorganized in most of segments. The LL1 was absent or oriented like DA3 (in 129/140 segments; [Figure 2J](#fig2){ref-type="fig"}, [Figure 2--- figure supplement 2](#fig2s2){ref-type="fig"}, [Video 4](#media4){ref-type="other"} and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}) a phenotype already observed in *col* mutant embryos ([@bib34]). The LT muscles were also often missing and some ventral muscles were absent or malformed, as previously reported ([Figure 2J](#fig2){ref-type="fig"}; [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}) ([@bib48]). Conversely, dorsal muscles and DT1 appeared normal ([Figure 2J](#fig2){ref-type="fig"}). *col^LCRM^-moeGFP* expression revealed a, sometimes complete or partial, DA3\>DA2 transformation ([Figure 2P,V](#fig2){ref-type="fig"}). *noc* mutant embryos also lacked DA3 Col expression at stage 15 ([Figure 2E,K](#fig2){ref-type="fig"} and [Figure 2](#fig2){ref-type="fig"}, [Figure 2--- figure supplement 2](#fig2s2){ref-type="fig"}, [Video 5](#media5){ref-type="other"} and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). Contrary to *eya* mutants, however, Col expression was detected at the PC stage (insets in [Figure 2E](#fig2){ref-type="fig"}), indicating a role of *noc* in maintenance of Col expression in the DA3 lineage. *col^LCRM^-moeGFP* expression further revealed that the DA3 could orient like a DT1 in most segments, indicating a DA3\>DT1 identity shift resulting in DT1 duplication ([Figure 2Q](#fig2){ref-type="fig"} and and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). LT muscles were also affected ([Figure 2K](#fig2){ref-type="fig"}). In *so* mutants, Col ectopic expression was specifically observed in DO5 ([Figure 2F,L](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, [Video 6](#media6){ref-type="other"}, and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). *col^LCRM^-moeGFP* expression both confirmed *col* ectopic expression in the DO5 muscle and its DA3-like orientation in a fraction of segments ([Figure 2R](#fig2){ref-type="fig"}, arrowhead, indicating a partial DO5\>DA3 identity shift in 79/116 segments ([Figure 2F,L](#fig2){ref-type="fig"} and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}).Video 2.3-D view of the muscle pattern in stage 16 *aop^1^* embryos, [Figure 2H](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.011](10.7554/eLife.14979.011)10.7554/eLife.14979.011Video 3.3-D view of the muscle pattern in stage 16 *edl^L19 ^*embryos, [Figure 2I](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.012](10.7554/eLife.14979.012)10.7554/eLife.14979.012Video 4.3-D view of the muscle pattern in stage 16 *eya^CII^/Df(2L)^BSC354^*embryos, [Figure 2J](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.013](10.7554/eLife.14979.013)10.7554/eLife.14979.013Video 5.3-D view of the muscle pattern in stage 16 *noc^35ba2^*embryos, [Figure 2K](#fig2){ref-type="fig"}**DOI:** [http://dx.doi.org/10.7554/eLife.14979.014](10.7554/eLife.14979.014)10.7554/eLife.14979.014Video 6.3-D view of the muscle pattern in stage 16 *so^3^*embryos, [Figure 2L](#fig2){ref-type="fig"}**DOI:** [http://dx.doi.org/10.7554/eLife.14979.015](10.7554/eLife.14979.015)10.7554/eLife.14979.015

In summary, we found that *aop, edl, eya, noc, and so* mutants display distinctive patterns of DL muscle defects and DA3 transformations, associated with modifications of Col expression (schematized in [Figure 2S--X](#fig2){ref-type="fig"}), indicating that each gene acts in different subsets of DL muscles, and/or at different steps of muscle identity specification.

Nau/MyoD is transiently expressed in PMC cells subject to high EGF-R signaling {#s2-4}
------------------------------------------------------------------------------

Understanding the specific muscle transformations observed in *aop, edl, eya, noc, and so* mutants required determining their expression patterns at the PMC, PC and FC stages. In order to access dynamic aspects of this expression, we used FISH with intronic probes which detect nascent transcripts and allow precisely determining temporal windows of transcription. To follow PC delamination events, we used Nau, the *Drosophila* ortholog of vertebrate myogenic regulatory factors (MRFs), a marker of PCs and FCs ([@bib49]; [@bib52]). High-resolution 3-D analyses allow us to unambiguously identify the DA2/AMP and DL PCs and the derived DA2, DA3 and DO5 FCs and AMP ([@bib34]; [Figure 1A](#fig1){ref-type="fig"} and [Figure 3--- figure supplement 1](#fig3s1){ref-type="fig"}, [Video 7](#media7){ref-type="other"}). In early stage 10 embryos, the first selected, DA2/AMP PC is recognizable as a large apical cell, expressing high Nau levels ([Figure 3B,B'](#fig3){ref-type="fig"}). At stage 11, after the DA2/AMP PC has divided, the DA3/DO5 PC is observed, adjacent to the DA2 FC ([Figure 3C](#fig3){ref-type="fig"}). 3-D analyses also revealed previously undescribed, low level Nau expression in two or three cells surrounding each PC being selected ([Figure 3B,F](#fig3){ref-type="fig"}; [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). This Nau expression pattern was reminiscent of subgroups of PMCs cells displaying higher level dpMAPK (di-phospho mitogen-associated protein kinase), diagnostic of EGFR activity ([@bib13], [@bib12]) and postulated to be cells primed to become PCs. Double staining confirmed that the Nau and dpMAPK patterns overlap, revealing that low level Nau expression corresponds to cells transitioning from PMC to PC, before reaching high level in selected PCs ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Using Nau staining allowed us to follow these cells and PCs in subsequent FISH experiments.Video 7.Multiple FCs originate from the Col-expressing PMC.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.016](10.7554/eLife.14979.016)10.7554/eLife.14979.01610.7554/eLife.14979.017Figure 3.*aop* and *edl* differential expression and roles during PC selection.(**A**) Schematic representation of the positions of DL PCs and FCs, relative to the A/P, D/V and proximal/distal axes in stage 10, 11 and 12 wt embryos ([Video 7](#media7){ref-type="other"}); the blue trapeziums indicate planes of section shown in panels (**B**--**K**) and (**R**--**U**); Col expression is in red. (**B**--**I**) ISH to *aop* (**B--E**) and *edl* (**F**--**I**) primary transcripts (red dots), in wt embryos stained for Col (blue) and Nau (green), at stages indicated above; early stage is abbreviated ste; two different planes of the same embryo are shown in **B** and **B'**, **F** and **F'**. *aop* transcription in the Col PMC (**B**), and the AMP (**D**). (**F**--**I**) *edl* transcription in all PCs, the AMP and the DA3 FC. (**B**,**F**) Nau accumulation in two to three Col PMC cells, below the emerging PC. (**J**,**O**) 3D reconstruction of the Col PMC during DA2/AMP and DA3/DO5 PC selection; Col staining, red, Nau, green. The embryonic stage indicated in each panel. (**J**, **K**) wt; (**J**) apical DA2/AMP PC (dotted white circle); (**K**) apical DA3/DO5 PC (dotted circle), DA2 FC and AMP (asterisks). (**L**, **M**) *aop* embryos; (**L**) premature DA3/DO5 PC selection; additional Nau-expressing PMC cells (arrow), become PCs, (**M**). (**N**, **O**) *edl* embryos; (**N**) no PC is selected; a group of 3 to 4 Nau-expressing cells is embedded in the Col PMC; (**O**) two PCs are simultaneously selected. (**P**--**U**) ISH to *col* primary transcripts (red), Nau staining (green); (**P**--**R**) wt; sequential *col* transcription in the PMC and DA2/AMP PC (**P**), DA3/DO5 PC (**Q**), and DA3 FC (**R**). (**S**) *aop* mutant: simultaneous *col* transcription in two apical PCs; increased number of low level Nau-expressing cells (green dotted circle). (**T**,**U**) *edl* mutant; ectopic col transcription in the DA2/AMP PC (**T**) and DA2 FC (**U**). (**V**) Measurement of the diameter of Col (red) and Nau (green) expressing domains in early stage 10 wt and *aop* embryos. The Col expression domain is identical (P value = 0,1410; ns) and Nau domain expanded in *aop* compared to wt (P value\<0,0001; \*\*\*\*), schematized on top of the statistics. Bars: 5 μm**DOI:** [http://dx.doi.org/10.7554/eLife.14979.017](10.7554/eLife.14979.017)10.7554/eLife.14979.018Figure 3---figure supplement 1.Snapshot for [Video 7](#media7){ref-type="other"}.Stage 12 embryo. Col (green) is expressed in a large promuscular cluster and the FCs at the origin of the DA3, DO5, LL1, DO3, DT1 and DO4 muscles, indicated on the screenshot. Col expression has been lost from the DA2 FC and the AMP at this stage. All FCs and the AMP express Nau (red). The Antero-Posterior, Dorso-Ventral and Distal-Proximal axes are indicated on the video by red, green and blue arrows, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.018](10.7554/eLife.14979.018)10.7554/eLife.14979.019Figure 3---figure supplement 2.Transient Nau expression in subsets of PMC cells.(**A**) Schematic representation of the positions of the DA2/AMP PC, relative to the A/P, D/V and proximal/distal axis in stage early 10 (st e10) and late 10 (st l10); the trapezium indicates planes of sections shown in panels (**B**--**C**). Nau expression is in blue. (**B**--**C**) wt embryos at st e10 (**B**) and st l10 (**C**) stained for Nau (blue) and dpERK (green). **B** and **B\'** are two planes of section across a small equivalence group of cells both expressing Nau and accumulating dpERK. The selected PC (**B\'**) is positioned apical to the equivalence group (**B**). (**C**) At a slightly later stage, only the PC maintains Nau and dpERK (arrow).**DOI:** [http://dx.doi.org/10.7554/eLife.14979.019](10.7554/eLife.14979.019)10.7554/eLife.14979.020Figure 3---figure supplement 3.Extended analysis of the *aop* muscle mutant phenotype.(**A**, **B**) stage 16 embryos stained for Col (red) and F-actin (green). (**A**) wt, (**B**) *aop^1^*mutant embryo displaying several DA3 (horizontal arrow) or LL1 (vertical arrow) muscles.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.020](10.7554/eLife.14979.020)

*aop and edl* activities control sequential DA2/AMP and DA3/DO5 PC selection {#s2-5}
----------------------------------------------------------------------------

FISH experiments indicated *aop* transcription in Col PMC cells ([Figure 3B](#fig3){ref-type="fig"}), but not PCs ([Figure 3B'--E](#fig3){ref-type="fig"}), indicating its repression during the PC selection process, consistent with a role in promoting FCM fate ([@bib12]) and being a target of the FCM TF Lameduck ([@bib18]). Conversely, *edl* transcription was not detected in PMC cells, but in PCs and the dorsal AMP and DA3 FC ([Figure 3F--I](#fig3){ref-type="fig"}). Thus *aop* and *edl* show sequential, complementary transcription patterns. In stage 10 *aop* mutant embryos, *col* transcription was detected in PMC cells as in wt ([Figure 3P,S and V](#fig3){ref-type="fig"}). However, a significantly increased number of cells expressing low Nau level revealed that *aop* down-regulation of EGF-R signaling was required to restrict Nau expression to PMC cells primed to become PCs ([Figure 3P,S,V](#fig3){ref-type="fig"}). Furthermore, 3-D reconstructions confirmed the presence of two apical cells expressing high Nau Level (21/27 PMCs with 2, and 6/27 with 1 apical PC), when only the DA2/AMP PC was observed in wt (30/35 PMC with 1 apical PC and 5/35 with no apical PC; [Figure 3J,L](#fig3){ref-type="fig"}). Thus, concomitant, early selection of two PCs in *aop* embryos prefigures the DA3\>DA2 transformation ([Figure 2T](#fig2){ref-type="fig"}). At stage 11, Nau remained expressed at high level in several cells, showing that supplementary PMC cells are primed to become PCs ([Figure 3M](#fig3){ref-type="fig"}, compare to). This corroborates the observation of several aligned DA3-like fibers revealed by phalloidin staining of stage 16 *aop* mutant embryos ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Conversely, in *edl* mutant embryos, no high Nau-expressing apical cell was observed at stage 10 (30/37 segments), when the DA2/AMP PC is selected in wt embryos. Rather, three to four small low Nau-positive cells remained embedded in the Col PMC ([Figure 3N](#fig3){ref-type="fig"} compare with [Figure 3J](#fig3){ref-type="fig"}) ([Figure 3O](#fig3){ref-type="fig"} compare to [Figure 3K](#fig3){ref-type="fig"}) both of which transcribed *col* ([Figure 3T](#fig3){ref-type="fig"} compare with [Figure 3Q](#fig3){ref-type="fig"}). Accordingly, *col* transcription was maintained in two cells at late stage 11, at positions corresponding to DA2 and DA3 FCs in wt embryos ([Figure 3U](#fig3){ref-type="fig"} compare with [Figure 3R](#fig3){ref-type="fig"}). In summary, we found that sequential PC selection is inversely compromised in *aop* and *edl* mutants. In absence of *aop*, the DA3/DO5, and supernumerary PCs are selected early, and in absence of *edl*, the DA2/AMP is selected too late.

We have previously shown that the time lag between DA2/AMP and DA3/DO5 PC selection coincided with a period of dorsal regression of Tin expression, such that only the first selected, DA2/AMP PC inherited Tin ([@bib7]; [Figure 4C--D\'](#fig4){ref-type="fig"}). Tin staining of *aop* mutant embryos showed that the two apical cells observed at stage 10 inherit Tin ([Figure 4E,E\'](#fig4){ref-type="fig"}), confirming advanced selection of the DA3/DO5 PC. Conversely, in *edl* mutants, none of the apical cells inherited Tin, confirming a delayed selection of the DA2/AMP PC ([Figure 4G,H\'](#fig4){ref-type="fig"}), consistent with both transcribing *col* ([Figure 3T,U](#fig3){ref-type="fig"}). To verify that the observed shifts in PC selection timing lead to shifts of PC identity, we analyzed *tup* transcription. As previously shown, only the DA2/AMP PC inherits Tin levels above the threshold required for *tup* activation ([Figure 4I](#fig4){ref-type="fig"}), leading in turn to *col* repression and initiation of *tup* auto-regulation ([@bib7]). We found that, in *aop* mutants, early selected PCs transcribed *tup* ([Figure 4J](#fig4){ref-type="fig"}), while in *edl* mutants, late selected PCs did not ([Figure 4K](#fig4){ref-type="fig"}), mirroring *col* transcription ([Figure 3T,U](#fig3){ref-type="fig"}). Together, Tin, *tup* and *col* expression data, and the DA3\>DA2 and DA2\>DA3 muscle transformations predominantly observed in *aop* and *edl* embryos, respectively, show that timely PC selection is essential for each PC to inherit different Tin levels and either initiate *tup* (DA2/AMP) or *col* (DA3/DO5) feed-forward positive loops. Positive auto-regulation, a hallmark of bistable systems ([@bib37]; [@bib54]), of either *tup* or *col* distinguishes between DA2 and DA3 identities ([@bib7]; [Figure 4L](#fig4){ref-type="fig"}).10.7554/eLife.14979.021Figure 4.*aop* and *edl* control the temporal sequence of PC selection.(**A**,**B**) Schematic representation of the DA2/AMP PC and FCs and DA3/DO5 PC, at stages 10 (**A**) and 11 (**B**); the blue trapeziums indicate the planes of section shown below. (**C**--**H'**) Tin (green) and Col (red) embryo staining. (**C**, **C'**) Tin expression in the DA2/AMP PC and underlying PMC cells. (**D**, **D'**) Tin expression has regressed dorsally; the DA3/DO5 PC and underlying PMC cells are Tin negative. (**E**--**F'**) *aop* mutants; (**E**, **E'**), stage 10, two Col and Tin-expressing PCs are selected; (**F**, **F'**) stage 11, Col positive, Tin-negative cells are selected. (**G**--**H'**) *edl* mutants; (**G**, **G'**), No PC is selected. (**H**, **H'**) Two PCs are selected after dorsal regression of Tin expression. (**I**--**K**) FISH to *tup* primary transcripts in wt (**I**) *aop* (**J**) and *edl* (**K**) stage 10 (**I**, **J**) and 11 (**K**) embryos, stained for Col (blue) and Nau (green). In wt embryos (**I**) *tup* expression is only detected in the first selected Col positive PC (DA2/AMP, 100% n = 27). In *aop* mutants (**J**), *tup* transcription is sometimes detected (17% n = 34) in a second Col positive PC (arrow). In *edl* mutants (**K**), *tup* transcription is frequently lost in Col positive PCs (82% n = 29). (**L**) Summary scheme of the *aop* and *edl* phenotypes; wt, late stage (stl) 10; only the first-born, DA2/AMP PC inherits Tin, and activates *tup*, preventing Col autoregulation (left) which occurs in the second born, DA3/DO5 PC, in absence of Tin and Tup, stage 11 ([@bib7]). In *edl* and *aop* mutants, the temporal sequence of PC selection is compromised; it occurs too early and too late in *aop* and *edl* mutants, respectively, leading to confusions of DA2 and DA3 fates. Bars: 10 μm**DOI:** [http://dx.doi.org/10.7554/eLife.14979.021](10.7554/eLife.14979.021)

*eya* and *so* act sequentially in specifying DA3 and DO5 identity {#s2-6}
------------------------------------------------------------------

*Drosophila eya* gives rise to 3 different mRNA and protein isoforms (*eya-RA, eya-RB, eya-RC)* corresponding to the alternate use of different Transcription Start Sites (TSS) (Flybase FBgn0000320; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). FISH performed with a probe complementary to a common coding region, *eya^e^*, detected *eya* expression in the Col PMC, DA2/AMP, DA3/DO5 and LL1/DO4 PCs and DO5 lineage ([Figure 5B--E,O](#fig5){ref-type="fig"} and [Figure 5--- figure supplement 2](#fig5s2){ref-type="fig"}). However, an intronic probe specific for transcripts initiated from the 5'-most TSS (*eya-RB^i^;* [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) revealed that *eya-RB* transcription was restricted to the AMP, DO5 FC/muscle and the LL1/DO4 PC ([Figure 5F--I,P](#fig5){ref-type="fig"} and [Figure 5--- figure supplement 2](#fig5s2){ref-type="fig"}), implying that, conversely, *eya-RA/RC* is specifically expressed in the PMC, the DA2/AMP and the DA3/DO5 PCs. This indicated a temporal shift in TSS, leading to sequential production of different Eya protein isoforms. In *eya* mutants, *col* transcription was detected in PMC cells like in wt (not shown), but prematurely lost in the DA3/DO5 PC, and undetectable in the DA3 FC ([Figure 5R,S](#fig5){ref-type="fig"}), showing that *eya-RA/RC *is required for sustained *col* transcription during PC specification. Reciprocally, both *eya-RA/RC* transcripts in the DA3/DO5 PC ([@bib24]) and *eya-RB* transcripts in the DO5 FC ([Figure 5T,U](#fig5){ref-type="fig"}) were lost in *col* mutants, revealing that Eya and Col positively regulate each other transcription. Whether, both *eya-RA/RC*, and *eya-RB* are under direct control of Col binding to a dedicated cis-regulatory module (CRM) ([@bib24]; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), or *eya-RB* control is indirect, and requires prior expression of *eya-RA/RC* at the PC stage ([Figure 5X](#fig5){ref-type="fig"}), remains unknown.10.7554/eLife.14979.022Figure 5.Sequential *eya* and *so* transcription and control of *col* transcription in distinct muscle lineages.(**A**) Schematic representation of the positions of DL PCs and FCs in stage 10, 11 and 12 wt embryos, reproduced from [Figure 3A](#fig3){ref-type="fig"}; the blue trapeziums indicate the planes of section shown below, panels (**B**--**M**). (**B**--**M** and **O**--**Q**) ISH to *eya* and *so* transcripts (red) in wt embryos stained for Col (blue) and Nau (green). (**B**--**E**), *eya* expression in the DA2/AMP (**B**), DA3/DO5 (**C**) AMP and DO5 FC (**D**) LL1/DO3 PC (**E**). (**N**) Schematic representation of the DL muscle pattern, DA3 in red and DO5 in grey. (**O**) DO5 *eya* expression. (**F**--**I**) *eya*-RB transcription in the AMP DO5 FC (**H**) and LL1/DO4 PC (**I**). (**P**) DO5 *eya*-RB transcription. (**J**--**M**, **Q**) *so* transcription in the DA2/AMP, DA3/DO5 and LL1/DO4 PCs, DO5 FC and muscle. (**R**,**S**) Loss of *col* transcription in the DA3/DO5 PC in *eya* mutants. (**T**--**U**) Loss of *eya*-RB transcription in *col* mutants (**U**). (**V**,**W**) *col* ectopic transcription in the DO5 FC in *so* mutants. Embryos in R-W are co-stained for Nau (green). (**X**) Summary diagram of *eya* and *so* expression and function in DL muscle lineages. Bars: 5 μm**DOI:** [http://dx.doi.org/10.7554/eLife.14979.022](10.7554/eLife.14979.022)10.7554/eLife.14979.023Figure 5---figure supplement 1.Schematic representation of the *eya* genomic region and transcripts.Schematic representation of the *eya* genomic region chromosomal positions Chr2L:6,525,000--6,550,000. The different *eya* transcripts (RA, RB, RC) initiated from different Transcription Start Sites are indicated. Red boxes indicate the position of the exonic (eya^e^) and intronic (eya-RB^i^) probes used for FISH experiments. Green boxes show RNA-PolII binding at the indicated embryonic stage (Zinzen et al., 2009). Two previously characterized mesodermal CRMs are indicated by blue ([@bib48]) and purple boxes, respectively. *eya_Col* CRM activity depends upon in vivo Col binding ([@bib24]).**DOI:** [http://dx.doi.org/10.7554/eLife.14979.023](10.7554/eLife.14979.023)10.7554/eLife.14979.024Figure 5---figure supplement 2.Sequential *eya* and *so* transcription.(**A**) Schematic representation of the DL PCs, FCs and muscles as in [Figure 5](#fig5){ref-type="fig"}. (**B**--**Q**) ISH to *eya* and *so* transcripts (red) in wt embryos stained for Col (blue) and Nau (green). To complement [Figure 5](#fig5){ref-type="fig"}, the red channel is show separately in black and white.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.024](10.7554/eLife.14979.024)10.7554/eLife.14979.025Figure 5---figure supplement 3.Loss of DA3 Col expression in *Six4* mutant embryos.(**A**) Stage 15 wt, and (**B**) homozygous mutant embryos for a null allele of *Six4*, *Six4^289^*. Col expression is detected in 100% of segments in wt embryos (n = 117), and lost in 84% of segments in *Six4* mutants (n = 249). In most of the remaining muscles, residual Col expression indicates a DA3\>DA2 transformation (arrow in **B**). Col expression is already lost at the PC stage in *Six4* mutants (insets in A,B), similar to the loss observed in *eya* mutants (See [Figure 2D](#fig2){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.14979.025](10.7554/eLife.14979.025)

Eya protein phosphatases interact with Six family TFs, Six4, Optix (Op) and So in *Drosophila* (see introduction). We found that *so* was transcribed in the DA2/AMP, DA3/DO5 and LL1/DO4 PCs and subsequently maintained only in the DO5 FC and muscle ([Figure 5J--M, Q](#fig5){ref-type="fig"} and [Figure 5--- figure supplement 2](#fig5s2){ref-type="fig"}). *col* transcription in DL PCs was normal in *so* mutants, showing that So is not required for *Eya-RA/RC* regulation of *col* transcription (not shown). On the contrary, *col* was ectopically transcribed in the DO5 FC ([Figure 5V,W](#fig5){ref-type="fig"}), showing that *so* activity contributes to repress *col* transcription in this lineage. *so* transcription in the DO5 FC and contribution to distinguishing between the DA3 and DO5 identities suggests that *so* could act downstream of N in this process ([@bib20]). The difference between the *eya* and *so* DA3 mutant phenotypes ([Figure 2D,F](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, and [Videos 4](#media4){ref-type="other"} and [6](#media6){ref-type="other"}) suggested that *eya* was partnering with *Six4* to positively regulate *col*. To verify this assertion, we analyzed DA3 Col expression in *Six4* mutants. The loss of Col expression ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}), very similar to that observed in *eya* mutants ([Figure 2D](#fig2){ref-type="fig"}), supports the conclusion that Eya partners with Six4 to positively, and with So to negatively regulate *col*. Thus, Six4 and So play distinct roles during muscle specification ([Figure 5X](#fig5){ref-type="fig"}).

Positional information; *noc* distinguishes between DA3 and DT1 identity {#s2-7}
------------------------------------------------------------------------

*noc* is required for DA3 Col expression and DA3 formation ([Figure 2](#fig2){ref-type="fig"}). *noc* and its paralog *elbow (elb*), act as transcription repressors in morphogenesis of appendages, tracheal branches and specification of monochromatic receptors in the retina ([@bib29]; [@bib50]; [@bib71]) but a function in myogenesis was not reported. A deficiency removing *elb (Df(2R)exel6035*) had no DL muscle phenotype, while the phenotypes of *noc^35ba2^* mutants and a deficiency removing both *elb* and *noc* were identical ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"} and [Figure 2E](#fig2){ref-type="fig"}). Thus, only *noc* is required for DL muscle specification. FISH experiments revealed *noc* transcription in Col PMC cells which express low Nau level, followed by the DA2/AMP, the DA3/DO5 and the LL1/DO4, but not the DT1/DO3 PC ([Figure 6B--E](#fig6){ref-type="fig"}). In *noc* mutants, *col* transcription was detected in the PMC and DA3/DO5 PC (not shown) but completely lost from the DA3 FC ([Figure 6F,G](#fig6){ref-type="fig"}), correlating with the loss of Col DA3 expression after the PC stage ([Figure 2E,K](#fig2){ref-type="fig"}). The DA3\>DT1 transformation observed at stage 15 in *noc* mutants ([Figure 2Q](#fig2){ref-type="fig"}) was therefore intriguing, since a DA3\>DA2 identity shift was observed in other mutants where DA3 Col expression was lost, namely *col, eya* and *Six4* ([Figure 2D](#fig2){ref-type="fig"} and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). Since DT1 identity requires S59 expression in the DT1 FC ([@bib46]), we analyzed *S59* expression in *noc* mutant embryos and found that it was ectopically expressed in the DA3 FC ([Figure 6H,I](#fig6){ref-type="fig"}), consistent with DA3\>DT1 transformation. This finding suggested that loss of DA3 Col expression in *noc* embryos was secondary to gain of S59 expression. To test this possibility, we expressed S59 in all myoblasts, using the Twist-Gal4 pan-mesodermal driver. While the muscle pattern was severely disorganized, loss of Col expression in Twi\>S59 embryos demonstrated S59 ability to repress *col* mesodermal expression ([Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}). We next analyzed *col* transcription in S59 mutants and found that it was ectopically transcribed in one posterior DL FC, likely DT1 ([Figure 6---figure supplement 1C,D](#fig6s1){ref-type="fig"}). On the one hand, these data confirmed that S59 represses *col* transcription in the DT1 lineage, via an incoherent feed-forward loop initiated by Col activation of *S59* in the DT1/DO3 PC ([@bib34]). On the other hand, *noc* and *S59* loss-of-function and *S59* gain-of-function data revealed a double negative regulatory cascade where *noc* repression of *S59* maintains *col* transcription in the DA3 lineage and DA3 identity ([Figure 6J](#fig6){ref-type="fig"}). Noc expression in the DA3/DO5 PC and not the DT1/DO3 PC ([Figure 6E](#fig6){ref-type="fig"}) thus distinguishes between DA3 and DT1 identities ([Figure 7](#fig7){ref-type="fig"}).10.7554/eLife.14979.026Figure 6.*noc* transcription and control of *col* and *S59* transcription in DL muscle lineages.(**A**) Relative positions of DL PCs and FCs between stages 10 and 12, reproduced from [Figure 3A](#fig3){ref-type="fig"}; the blue trapeziums indicate the planes of section shown below, panels (**B**--**E**). (**B**--**E**), Embryos co-stained for Nau (green) and Col (blue); (**B**) *noc* transcription (red) in a small subset of Col PMC cells expressing low Nau level (**B**), the DA2/AMP (**B'**), DA3/DO5 and DA3 and DO5 FCs (**C**,**D**) and LL1/DO4 but not the DT1/DO3 PC (**E**). (**F**--**I**) Embryos stained for Nau (green) and (**H**,**I**) Col (blue). (**F**, **G**) loss of *col* transcription in the DA3 FC (red dots) in noc mutants. (**H**) wt *S59* transcription in DT1 (red dots, arrow) and (**I**) ectopic transcription in the DA3 FC (arrowhead) in noc mutant embryos. (**J**) Summary diagram of noc expression and function in DL muscle lineages. Bars: 5 μm**DOI:** [http://dx.doi.org/10.7554/eLife.14979.026](10.7554/eLife.14979.026)10.7554/eLife.14979.027Figure 6---figure supplement 1.S59 represses *col* transcription.(**A**, **B**) stage 16 embryos stained for Col (red) and β3-tubulin (green). (**A**) wt, (**B**) embryo expressing S59 under control of the *twist-gal4* mesodermal driver. The muscle pattern is strongly disorganized, and Col muscle expression is lost. (**C**,**D**) stage 13 embryos stained for *col* primary transcripts (red), Col (green) and Nau (blue). (**C**) wt; the arrow indicates the posterior group of cells giving rise to the DT1 and DO3 FCs. At this stage, *col* expression is rarely detected in these cells (6% of segments, n = 52). (**D**) *S59* mutant embryo. *col* expression is maintained in at least one posterior cell, likely the DT1 FC (81% of segments, n = 65).**DOI:** [http://dx.doi.org/10.7554/eLife.14979.027](10.7554/eLife.14979.027)10.7554/eLife.14979.028Figure 6---figure supplement 2.*eya* and *noc* are required for Kr expression in the LL1 FC.(**A**--**F**) Stage 12 embryos stained for Col (green) and Kr (red). (**A**) wt, co-expression of Col and Kr in the LL1 FC (horizontal arrow). Kr expression is detected in *aop^1^* (**B**), *edl^L19^* (**C**) and *so^3^* (**F**), and lost in *eya^CII^/Df(2L)^BSC354^*(**D**) and *noc35^ba2^* (**E**) mutant embryos. Of note, Kr expression is lost in DL, but not dorsal FCs (asterisks).**DOI:** [http://dx.doi.org/10.7554/eLife.14979.028](10.7554/eLife.14979.028)10.7554/eLife.14979.029Figure 7.Intertwined transcriptional control of DL muscle identity: A progressive resolution of the possible.Diagrammatic representation of transcription regulatory interactions and loops operating in DL muscle identity specification. One abdominal segment is considered. 3 steps are indicated on top and color-shaded. Left, PC selection; the A/P axis is on the abscissa and the developmental time on the ordinate. *aop* and *edl* positively and negative regulate Nau expression (blue circle) in a subset of PMC cells, favoring and inhibiting selection of PCs from PMC cells, respectively. Center, PC specification: the dorsal DA2/AMP and dorso-lateral DA3/DO5, LL1/DO4 and DT1/DO3 PCs are represented. Right, FC specification; only the DA3 and DO5 lineages are detailed. Color coding of expression of the different iTFs, and the names of their vertebrate orthologs are indicated. Genes and either positive (arrow), or negative (crossed line) regulatory steps identified in this study are drawn in black; previously reported interactions are in grey.**DOI:** [http://dx.doi.org/10.7554/eLife.14979.029](10.7554/eLife.14979.029)

Analysis of the DL muscle phenotypes showed that formation of the LL1 muscle is also affected in *noc, aop* and *eya* mutants ([Figure 2K,W](#fig2){ref-type="fig"} and [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}). Kr was previously shown to be expressed in the LL1 PC and required for LL1 development ([@bib60]). We found that Kr expression in the LL1/DO4 (but not DA1) PC required both *noc* and *eya* activity, but neither *aop* nor *col* ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}) ([@bib34]). These data further underline the intricate wiring and combinatorial nature of transcriptional regulations specifying muscle identities ([Figure 7](#fig7){ref-type="fig"}).

Discussion {#s3}
==========

A 3-steps model of muscle identity specification has been put forward 18 years ago in *Drosophila*, based on a limited repertoire of muscle iTFs ([@bib13]). In this work, we took an unbiased genetic approach and focused on a small group of muscles, to identify new transcription regulators of muscle identity. By combining functional and expression analyses of these new iTFs at the primary transcripts level, with previous data, we propose a novel, dynamic view of the transcriptional control of muscle identity by evolutionarily conserved TFs.

Noc, a new iTF responding to multimodal information {#s3-1}
---------------------------------------------------

Noc and Elb are two transcription repressors belonging to the NET family of C2H2 zinc finger proteins ([@bib29]; [@bib50]). Until now, identification of a Tin-dependent mesodermal *noc* enhancer was the only suggestion of a possible function in muscle development ([@bib42]). We show here that *noc* is required for distinguishing between DA3 and DT1 muscle identities. Primary transcript analyses revealed that *noc* maintenance of *col* transcription in the DA3 lineage involved a double Noc ---\|*S59* ---\|*col* negative loop. Col activation of S59 expression ([@bib34]) initiates a negative, \'incoherent\' feed-forward loop in the DT1/DO3 PC, resulting in Col repression and DT1 identity. Noc breaks this loop in the DA3 lineage ([Figure 7](#fig7){ref-type="fig"}). *noc* is transcribed in myoblasts expressing low Nau level whose number is controlled by EGF-R signaling, and selected PCs ([Figure 6](#fig6){ref-type="fig"} and [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). However, it is not transcribed in the DT1/DO3 PC which is specified under control of abdominal Hox proteins ([@bib33]). Thus *noc* regulation integrates multimodal signaling and positional inputs. Functions of vertebrate NET proteins Nolz-1/Nolz2 and ZNF503/nlz1 have, so far, been addressed in the central nervous system. Yet, zebrafish *Znf503* and mouse *nolz1* are expressed in branchial arches (zfin ID: ZDB-Gene-031113-5, genebank accession number NM-198840; [@bib14]). Whether this expression corresponds to migrating myoblasts which contribute to facial muscle development and express orthologs of other iTFs studied here ([@bib51]; [@bib63]; [@bib69]; [@bib57]; [@bib25]), remains to be explored.

Temporal control of muscle PC selection {#s3-2}
---------------------------------------

Our previous finding that several PCs are sequentially selected from the Col PMC and each express a specific iTF code brought to light the importance of time in muscle identity specification ([@bib7]). We report here that *aop* and *edl*, are required for the robustness of sequential selection of the DA2/AMP and DA3/DO5 PCs. A consequence of lack of Aop function is the premature, concomitant selection of several Nau-expressing PCs, when sequential in wt embryos. These data indicate that Aop acts to restrict EGF-R MAPK activity to prospective PCs, as previously suggested ([@bib12]). Inversely, *edl* expression in selected cells and delayed PC delamination in *edl* mutant embryos indicate that Edl ensures timely progression of primed cells to a stable PC fate. Thus, proper regulation of EGF-R signaling effectors is both required for the proper number and temporal sequence of PC selections. During eye development, the differentiation of all ommatidial cell types is triggered in a stereotypical sequence by reiterated EGFR use ([@bib36]). Likewise, EGF-R signalling regulates pulses of cell delamination from the ectoderm ([@bib9]). Whether pulses of EGF-R signalling control serial PC selection remains to be determined. Parallels between serial PC selection and successive waves of neuroblast (NB) selection ([@bib27]; [@bib5]) are striking. However, in NB lineages, the focus of investigation has shifted to the sequential expression of Temporal Transcription Factors (TTFs) in each NB progeny, which specifies the temporal identity of neurons ([@bib41]), and how birth time controls NB identity has not been determined.

Nau expression in early steps of myogenesis. A new Nau function? {#s3-3}
----------------------------------------------------------------

Our observation of an increased number of Nau-positive cells in *aop* mutants revealed that Nau/MyoD is expressed in myoblasts primed to a PC fate. Nau role in generic myogenesis versus identity aspects has been debated ([@bib2]; [@bib70]). We have previously proposed that Nau iTF functions could reflect lineage-dependent cooperation with other iTFs ([@bib34]). Another b-HLH protein, Lethal of Scute (L(1)sc), has been proposed to act as a promuscular gene ([@bib11]), based on its pattern of expression and regulation in PMCs and PCs, and by analogy to the role of proneural b-HLH proteins in NB selection. Yet, only minor muscle patterning defects were observed in *l(1)sc* mutants ([@bib11]). The detection of Nau expression in PMC cells subject to high EGF-R signaling raises the possibility that Nau could play earlier functions than previously thought in the PC specification process.

Translation of developmental time into muscle identity {#s3-4}
------------------------------------------------------

The time lag between DA2/AMP and DA3/DO5 PC emergence coincides with dorsal regression of Tin expression, due to an auto-regulatory circuit in which Tin progressively limits its own transcription ([@bib43]). We previously showed that only the DA2/AMP PC inherited Tin ([@bib7]). Considering Tin levels as a translation of developmental time, our new results show that EGF-R control of serial PC selection converts this translation into sharp transcriptional decisions and ultimately distinct muscle identities ([Figures 4](#fig4){ref-type="fig"} and [7](#fig7){ref-type="fig"}). Tup and Col direct up-regulation of their own transcription after the PC stage ([@bib33]; [@bib7], [@bib8]) can explain why small differences in initial expression levels are transformed into stable muscle fates. Our data thus provide a new paradigm for how birth timing controls cell identity during development ([Figure 4L](#fig4){ref-type="fig"}).

Different Eya isoforms and Six partners are sequentially involved in muscle development {#s3-5}
---------------------------------------------------------------------------------------

*Drosophila* Six proteins, Six4, So and Op correspond to vertebrate Six1/2, Six4/5 and Six3/6, respectively ([@bib44]). Six1/2/4/5 proteins have been reported to interact with *eya* in controlling the myogenic progenitor cell population in mouse, while no role was found for Six3/6 in this process ([@bib59]). Likewise, we did not observe DL muscle pattern defects in embryos lacking *op (Df(2R)Exel6055). Drosophila Six4* was previously proposed to interact with Eya in regulating somatic muscle development, both genes showing similar expression pattern ([@bib19]; [@bib48]). Tin in vivo binding to the *so* locus ([@bib48]; [@bib42]) raised the possibility that *so* could also be involved in muscle development. Interestingly, temporal ChIP profiles indicated Tin binding to *six4* earlier than to *so* ([@bib42]), suggesting sequential regulation. Our data show that one *eya* isoform, *eya-RB*, is transcribed later than the other isoforms (*eya-RA/RC*, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), owing to a switch in TSS, correlating with the profile of in vivo RNA polymerase II binding ([@bib6]). Together, these expression data and our finding that *eya* and *Six4* regulate positively, and *so* negatively, *col* transcription, suggest that *Eya* could switch from activator to repressor, by changing partner, from Six4 to So. We thus hypothesize that sequential partnering of different Eya isoforms and Six proteins could contribute the diversity of iTF codes and muscle morphologies ([Figure 7](#fig7){ref-type="fig"}). Various contributions of mouse Six1/2/4 to the Pax3/MyoD transcription regulatory network controlling early myogenesis in different embryonic territories have recently been reported ([@bib59]). It would be interesting to determine whether different *eya* isoforms are also involved in different Six partnerships and control different facets of muscle development in vertebrates.

An integrated view of the transcriptional control of muscle identity {#s3-6}
--------------------------------------------------------------------

Characterisation of *aop, edl, eya, noc* and *so* functions and transcription dynamics revealed that distinguishing between DA3, versus DA2, DT1 or DO5 identities involves specific sequences of transcriptional regulations integrating temporal and positional cues ([Figure 7](#fig7){ref-type="fig"}). The functions of these, and previously characterized iTFs, underline the intricacy of positive and negative regulatory loops acting at successive steps in different muscle lineages ([Figure 7](#fig7){ref-type="fig"}). Besides clear transformations suggestive of complete identity switch, a significant fraction of muscles show incomplete transformations in iTF mutant embryos. This supports the idea that, rather than lineage-specific \'master iTFs\', stereotypy of Drosophila muscle patterns relies upon combinatorial inputs of multiple iTFs during PC and FC specification. The finding that TFs combinatorically specify muscle identity ([@bib34]; [@bib23]; [@bib8], this report) indicates that activation of their target genes is context-dependent and involves multiple cis-regulatory elements. Multiple levels of cross-regulation ([Figure 7](#fig7){ref-type="fig"}) could provide robustness to the final muscle pattern.

While a function of Nolz proteins in the mesoderm remains to be investigated, Nkx2.5, Eya, Six1, Islet1, Col/Ebf and MyoD, are core components of transcriptional regulatory networks controlling the development of pharyngeal/facial muscles originating from the cardio-pharyngeal territory in chordates. Our data raise the possibility that these conserved mesodermal TFs could combinatorically control muscle regional diversity in vertebrates, attested by human muscular dystrophies ([@bib32]). but whose molecular basis remains poorly understood. It is reasonable to speculate that these TFs have been co-opted in different wirings during evolution to generate the muscle lineage diversity found in the animal kingdom.

Materials and methods {#s4}
=====================

Screening procedure and mutant alleles {#s4-1}
--------------------------------------

Deficiency lines from the Bloomington Drosophila Stock Center were balanced over a CyO--*wg--LacZ* chromosome to genotype embryos ([@bib15]). Screening for embryonic phenotypes was as in [@bib15], except that embryos were stained with a monoclonal mouse antibody against the Col protein ([@bib30]). Genetic complementation assays were used to identify genes in chromosomal deficiencies whose loss led to DA3 phenotype. Homozygous *aop^1^, edl^L19^, eya^CII/IID^, so^3^, noc^35ba2^, salm^1^, and col^1 ^*homozygous mutants showed muscle phenotypes identical to trans-heterozygous mutants over deficiency. They were thus considered as null alleles and consistently used for phenotypic analyses. For *eya* analysis, we used *eya^CII/IID^/Df(2l)BSC354* trans-heterozygous embryos as *eya^CII/IID^* homozygous embryos present a strong myoblast fusion defect (not shown), not observed in transheterozygous and probably due to a secondary mutations on the *eya^CII/IID^* chromosome. Col::moeGFP expression under control of a late mesodermal *col* CRM (*col^LCRM^*; previously named 2.6_0.9*c*; [@bib30]) was used to visualize the DA3 muscle contours in mutant embryos. The *col* PMC cells and PCs were visualized in *col* mutant embryos by LacZ expression under control of the early mesodermal col CRM, *col^ECRM^* (previously CRM276; [@bib33]). For all deficiency screening, sample size was estimated empirically (\>100 stage 14--16 embryos, in duplicates). For *aop, edl, eya, so, and noc,* mutant analyses, sample sizes are indicated in the text and the legend of [Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"}.

Immunohistochemistry, in situ hybridization and imaging {#s4-2}
-------------------------------------------------------

Antibody staining and in situ hybridization with intronic probes were as described previously ([@bib30]). Primary antibodies were: mouse βPS integrin, anti-Col ([@bib30]), anti-GFP (Torrey Pines Biolabs), anti-β-galactosidase (Promega, Madison, Wisconsin), rabbit anti-Tin (Manfred Frasch, Erlangen, Germany), anti-Nau (Bruce Paterson, Bethesda, USA), anti-Kr (Ralf Pflanz, Goettingen, Germany), anti-β3-tubulin (Renate Renkawitz-Pohl, Marburg, Germany). Secondary antibodies were: Alexa Fluor 488- and 555-conjugated antibodies (Molecular Probes), and biotinylated goat anti-mouse (Vector Laboratories). Digoxygenin-labelled antisense RNA probes were transcribed in vitro from PCR-amplified DNA sequences, using T7 polymerase (Roche Digoxigenin labelling Kit). For *aop, edl* and *eya-RB*, 3 non overlapping 600 nucleotide (nt) probes were pooled together; for *noc,* a single probe spanning the entire 302 bp intron; for *so,* a 2771nt probe hydrolyzed to \~600nt fragments (Cox et al., 1984). The primer pairs used to amplify the different intron fragments are listed below, with the T7 promoter indicated by small characters.

*aop1*: CTCATTGTATGCACGGTACG

*aop1*T7: ccgaattctaatacgactcactatagggATAGCTGCGGCAGAAGCAGG

*aop2*: GCAACAGCAACACTCCAATC

*aop2*T7: ccgaattctaatacgactcactatagggAGACGGTGCGGGCAGAAATTGGG

*aop3*: AAGAGAAAGAGCACGGCAAG

*aop3*T7: ccgaattctaatacgactcactatagggAGATCGGCGACGTTCTCCGAGAC

*edl1*: GGGAGGTGGAAATGACAAAC

*edl1*T7: ccgaattctaatacgactcactatagggCATCGTCTGCCTGACGTCTG

*edl2*: CCAAATATCGCCGATAAGCC

*edl2*T7: ccgaattctaatacgactcactatagggAGACTGCGCACAGGATGCACACC

*edl3*: GAAGATCGACCAGACTTAGG

*edl3*T7: ccgaattctaatacgactcactatagggAGAAGCGGCGTCGAGATTCCCAG

*eyaRB1*: GTTCCTCTAGCTCCGAAATG

*eyaRB1*T7: ccgaattctaatacgactcactatagggTTACGCCGGAGTTGTGAGGG

*eyaRB2*: GACAGCATCGGAGACAACAC

*eyaRB2*T7: ccgaattctaatacgactcactatagggCCCGGCCACAAACGAGAAAC

*eyaRB3*: AGCCCAGTCAAATGCGAAAC

*eyaRB3*T7: ccgaattctaatacgactcactatagggATGCGTGTCCGTGTCGCTAC

*noc1*: CGACGGTTAGTATTGACTAAG

*noc1*T7: ccgaattctaatacgactcactatagggGGCGTCCATCTGTTATGAATAAAATG

*so1*: TCCACGTTTCCAAGTTGGCTACTC

*so1*T7: ccgaattctaatacgactcactatagggAATGCGGCATGTTCGATGCTCGATAATCGG

Confocal sections were acquired on Leica SP5 or SPE microscopes at 40× magnification, 1024/1024 pixel resolution. Images were assembled using ImageJ and Photoshop softwares. 3-D reconstructions of the topology of DL PCs and FCs were made from optimized section, \'using volocity (PerkinElmer) or Imaris (Bitplane) Softwares\'. Images presented are representative of observations of at least 10 embryos per genotype at a given stage and between five and six segments per embryo. To compare the size of the Col and Nau expression domains in *wt* and *aop* mutants, optimized stacks of double-stained embryos in the same orientation were flattened, and the largest diameter of each domain measured. Statistical analysis was with GraphPad Prism5 using unpaired t-test.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Genetic dissection of the Transcription Factor code controlling serial specification of muscle identities in *Drosophila*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The identity of muscle progenitors and their founder cell progeny is specified by a combinatorial code of expression of transcription factors. In this work, the authors focus on the Collier expressing DA3 muscle in *Drosophila*. By genetic analysis, they identify known genes for which a role in muscle development has not yet been described and expand our knowledge on the role of genes already known to affect muscles. New roles for the genes Anterior Open, ETS domain lacking, Eyes absent, No Ocelli, and Sine oculis are demonstrated in progenitor and founder cell specification. The authors examine muscle perturbations and changes in expression of specific markers to delineate the precise decisions involved in muscle specification. This manuscript provides the most complete example to date of this cascade of events and reveals the involvement of dynamic feedback loops. Furthermore, it presents the novel finding that the timing of progenitor cell specification is critical to its subsequent development. Overall, this is important work that demonstrates the dynamic nature of the muscle identity specification process and its sequential nature.

Prior to acceptance, the following points should be addressed:

Major revisions

1\) Quantification and 3D data are necessary for mutants ([Figure 2](#fig2){ref-type="fig"}). Some information is provided on the frequency of the defects (e.g. transformations) but could be expanded and should be placed in a table. Some transformations are very hard to see (2H), and might be aided by viewing the data in 3D.

2\) 3D data for [Figure 4](#fig4){ref-type="fig"} would also be beneficial, as it is very hard to interpret the Col pattern in the mutants from the data provided.

3\) The FISH for *eyaRB* and so are not convincing. This is an important point for the manuscript since expression of these genes in muscle progenitors is the only evidence consistent with an autonomous role.

4\) Eya and, in particular, *aop* mutants exhibit defects in many muscles. What is the evidence that these defects are autonomous in the mesoderm and/or in DA3 specifically? Can DA3 be rescued by expression of these genes within the mesoderm? Though unlikely to work, have the authors tried knockdown of any of these genes in the mesoderm?

5\) To show the Noc ---\| *S59* ---\|*col* double negative circuit/gate, the authors should attempt to rescue the *noc* phenotype with a *S59* loss-of-function; not just mimic the *noc* phenotype with a *S59* gain-of-function, which is consistent with the model, but not an unequivocal demonstration.

6\) While it may be beyond the scope, changes in the expression profiles of markers (e.g. for DA2) would provide much stronger evidence of DA2-DA3 transformations than subjective studies using the shape to infer an autonomous/intrinsic change.

7\) In general, the authors could be more explicit about the possible impact of the *aop* and *edl* mutations on EGFR signaling. Placing the phenotypes in the context of loss- of gain-of- EGFR signaling would be informative if this is possible in the time frame of the revisions.

In the model shown in [Figure 7](#fig7){ref-type="fig"}, adding EGFR would be helpful, including the possible impacts of *aop* and *edl*. This is also true for [Figure 4I](#fig4){ref-type="fig"}. It seems that *aop* could act to restrict EGFR-MAPK activity in the prospective DA2/AMP progenitor cells, whereas *edl* could be necessary for proper EGFR-MAPK, but this is not clear in the summary.

8\) The paper is generally a bit difficult to read for non-specialists of muscle development in *Drosophila*, but the summary diagrams inserted in various figures help a lot. In particular, it is difficult to understand how the authors identified the genes starting from the deficiencies; a simple explanation would help the non-specialist.

10.7554/eLife.14979.031

Author response

*Major revisions*

*1) Quantification and 3D data are necessary for mutants ([Figure 2](#fig2){ref-type="fig"}). Some information is provided on the frequency of the defects (e.g. transformations) but could be expanded and should be placed in a table. Some transformations are very hard to see (2H), and might be aided by viewing the data in 3D.*

Following the referees' request, 3D views of *aop, edl*, eya, *noc* and so mutant embryos have been added ([Videos 1](#media1){ref-type="other"} to 6, and associated [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). A table describing in more detail the frequency of the defects observed in the different mutants has also been added ([Figure 2---source data 1](#SD2-data){ref-type="supplementary-material"} which replaces former [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

*2) 3D data for [Figure 4](#fig4){ref-type="fig"} would also be beneficial, as it is very hard to interpret the Col pattern in the mutants from the data provided.*

We agree that 3D visualization of Col and Tin expression would be optimal. However, the surrounding of (low-level) Col expressing PCs by Tin expressing cells makes it very hard to properly visualize them in 3D. We think that the 2D figures shown in [Figure 4](#fig4){ref-type="fig"} clearly illustrate the abnormal timing of Col-expressing PC selection in either aop or edl mutants. To re-enforce this point, we analyzed the pattern of tup transcription in aop and edl mutants (new panels J-K in [Figure 4](#fig4){ref-type="fig"}), which further strengthens our model, [Figure 4L](#fig4){ref-type="fig"} (see also answer to point 6).

*3) The FISH for eyaRB and so are not convincing. This is an important point for the manuscript since expression of these genes in muscle progenitors is the only evidence consistent with an autonomous role.*

We are not exactly sure of why our in situ data are "not convincing". [Figure 5B-E](#fig5){ref-type="fig"} shows that *eya-RB* transcripts are detected in the DO5 FC (distinguishable from DA3 by its lack of Col) and the DO5 muscle [Figure 5 O](#fig5){ref-type="fig"}. Likewise, *so* transcription in the DA2/AMP, DA3/DO5, and LL1/DO4 PCs, and maintenance in the DO5 lineage, is clearly shown by [Figure 5 L](#fig5){ref-type="fig"} and Q.

Nevertheless, to better address the reviewers' concern, and better highlight the *eya* and *so* transcription patterns, we made a supplementary figure ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}) showing only the *in situ* signal (red channel). The specific overlap of *eyaRB* and *so* transcription in the DO5 FC and muscle is consistent with the DO5 *so* phenotype and a cell autonomous role of EyaRB/So (see also answer to point 4). The early requirement of Eya in the DA3/DO5 PC precludes analysis of its specific role in the D05 lineage.

*4) Eya and, in particular, aop mutants exhibit defects in many muscles. What is the evidence that these defects are autonomous in the mesoderm and/or in DA3 specifically? Can DA3 be rescued by expression of these genes within the mesoderm? Though unlikely to work, have the authors tried knockdown of any of these genes in the mesoderm?*

We agree that identification of *aop* and *eya* mutants, using DA3 Col expression and muscle formation as a read-out, does not prove that *eya* and *aop* are cell-autonomously required in the DA3 muscle. However, cell autonomous function of *eya* and *aop* in somatic muscles is supported by previous genetic and molecular analyses (Halfon et al., 2000, Carmena et al., 2002, Liu et al., 2009; Ciglar et al., 2014). Since Aop is a transcription factor, both *aop* transcription in PMCs and the increased PMC expression of Nautilus which is observed in *aop* mutants ([Figure 3K-O,V](#fig3){ref-type="fig"}) support a cell autonomous role in PC specification, a function previously suggested in dorsal Eve-expressing lineages (Carmena et al., 2002). Our present data showing the sequential modification of Nau expression in the DL PMC, and *col* transcription during the PC selection process in *aop* mutants add a dynamic dimension to previously published work. Because of its role in FCM versus PC identity (Carmena et al., 2002, our data) we suspect that pan\>mesodermal expression of *aop* would not allow to follow rescue of individual muscles. It will certainly be rewarding to perform both *aop* gain of function and loss of function experiments when drivers allowing to specifically target each step in the PC selection process become available.

*eya* (Liu et al., 2009 and this paper) and *six4* (Clark et al., 2006) expression in the somatic mesoderm together with the *eya* mutant phenotype ([Figure 2](#fig2){ref-type="fig"}, [5](#fig5){ref-type="fig"}), and cross-regulation between *eya* and *col* in the DA3 PC ([Figure 5](#fig5){ref-type="fig"} and de Taffin et al., 2015) all support the conclusion of a cell-autonomous role of Eya in the DA3 muscle. To support our assertion of an Eya/Six-4 cell autonomous role in DA3 specification, we examined DA3 Col expression in *Six4* mutant embryos. The data show a very similar phenotype to that observed in *eya* mutants with loss of DA3 Col expression in 84% of segments at stage 15, a loss already observed at the PC stage. The *six4* mutant DA3 phenotype is now shown in a new supplementary figure ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"} and revised text, paragraph 2 subsection "*eya* and *so* act sequentially in specifying DA3 and DO5 identity").

*5) To show the Noc ---\| S59 ---\|col double negative circuit/gate, the authors should attempt to rescue the noc phenotype with a S59 loss-of-function; not just mimic the noc phenotype with a S59 gain-of-function, which is consistent with the model, but not an unequivocal demonstration.*

Our model, [Figure 6J](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}, proposes that *noc* expression prevents S59 repression of *col* transcription in the DA3 lineage, a conclusion admitt*edl*y relying in part on S59 gain of function experiments. We could not succeed analyzing double *noc*/S59 mutant embryos in the imparted time. Therefore, in order to strengthen the Noc ---\| *S59* ---\|*col* double negative loop, we looked at *col* transcription in loss of function *S59* mutants. Ectopic col transcription was specifically observed in one abdominal DL FC where *noc* is not expressed ([Figure 6E](#fig6){ref-type="fig"}), likely the DT1 FC (Knirr et al., Development 1999). This ectopic transcription, which confirms *col* repression by S59 in cells which do not express *noc* is shown in new panels C and D, in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, with accompanying text, paragraph 1 subsection "Positional information; *noc* distinguishes between DA3 and DT1 identity".

*6) While it may be beyond the scope, changes in the expression profiles of markers (e.g. for DA2) would provide much stronger evidence of DA2-DA3 transformations than subjective studies using the shape to infer an autonomous/intrinsic change.*

Following the referees' suggestion, we have analyzed *tup* transcription in the DA2/AMP and DA3/DO5 PCs in *aop* and *edl* mutant embryos, which predominantly show DA3\>DA2 and DA2\>DA3 transformations, respectively.

In wt embryos, *tup* is transcribed in the first-born PC selected from the *col*-expressing PMC, leading to *col* repression in this PC and DA2 identity. *tup* is not transcribed in the second-born PC, which maintains *col* transcription and adopts a DA3 identity (Boukhatmi et al., 2012). Our new data show a significant number of cases where both PCs transcribe *tup* in *aop* mutant embryos, while neither transcribes *tup* in *edl* mutants (New panels I-K in [Figure 4](#fig4){ref-type="fig"} and text paragraph 2 subsection "*aop* and *edl* activities control sequential DA2/AMP and DA3/DO5 PC selection"). In addition to confirming a precocious selection of the DA3 PC in *aop* mutants, and delayed selection in *edl* mutants, the *tup* transcription data complement *col* transcription data ([Figure 3](#fig3){ref-type="fig"}) and provide further evidence that the DA3\>DA2 and DA2\>DA3 morphological transformations observed in *aop* and *edl* mutants, respectively, result from PC mis-specification due abnormal timing of selection.

*7) In general, the authors could be more explicit about the possible impact of the aop and edl mutations on EGFR signaling. Placing the phenotypes in the context of loss- of gain-of- EGFR signaling would be informative if this is possible in the time frame of the revisions.*

Complete loss of EGF-R signalling in star mutants, leads to loss of DL muscles (except for DT1; [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), whereas supernumerary PCs form in Ras1Act mutants (Carmena et al., 1998), The aop and edl mutations display more subtle, identity phenotypes. We are therefore conscious that the impact of aop and edl mutations on timing and level of EGFR signaling deserves further investigation, but also feel that it falls beyond the scope of this manuscript.

*In the model shown in [Figure 7](#fig7){ref-type="fig"}, adding EGFR would be helpful, including the possible impacts of aop and edl. This is also true for [Figure 4I](#fig4){ref-type="fig"}.*

In absence of more detailed investigation of EGF-R signaling (see above) we would prefer not to be more specific on the precise role of *aop* and *edl* in the different DL PCs in [Figure 7](#fig7){ref-type="fig"} and [4I](#fig4){ref-type="fig"}. In order for the scheme [Figure 7](#fig7){ref-type="fig"}, to better reflect new data, we added Nautilus regulation by *aop* and *edl* during the PC selection process.

*It seems that aop could act to restrict EGFR-MAPK activity in the prospective DA2/AMP progenitor cells, whereas edl could be necessary for proper EGFR-MAPK, but this is not clear in the summary.*

We have modified the text accordingly, (subsection "Temporal control of muscle PC selection")

*8) The paper is generally a bit difficult to read for non-specialists of muscle development in Drosophila, but the summary diagrams inserted in various figures help a lot. In particular, it is difficult to understand how the authors identified the genes starting from the deficiencies; a simple explanation would help the non-specialist.*

Following the recommendation of the referees, we modified the text (paragraph 2 subsection "A genetic screen for muscle defects") to better explain how we went from deficiencies to genes. We also tried our best to render the text less difficult to read for non-specialists of *Drosophila* muscle development and added a few more references to studies in vertebrates. We also modified the legend of summary model [Figure 7](#fig7){ref-type="fig"}.
